Please login to the form below

Cello Health BioConsulting adds another member to its senior team

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of James McDermott as Vice-President.

Jim McDermott joins Cello BioConsulting with over 30 years of experience, with the past 20 focused specifically on the life sciences industry.  During his extensive career, he has helped hundreds of biotech, pharmaceutical and medical technology companies with some of their most challenging and important strategic decisions.  He specializes in working with companies/teams that are seeking fresh thinking on issues such as commercialization strategy, acquisition/partnership, forecasting/valuation and strategic planning.  Prior to joining Cello Health BioConsulting he was a senior member of Campbell Alliance’s Corporate Development Practice and before Campbell he led Decision Resources global consulting business for over 10 years.  

Julia Ralston, CEO of Cello Health US, commented, “We are delighted to welcome another very senior and experienced practitioner into the Cello Health BioConsulting team.  Jim’s extensive career, broad business background and therapeutic insight will be a tremendous addition to our team and is further testament to the growing value of the Cello Health organization and a significant step in establishing us as one of a small number of high quality, technically led advisers to the pharmaceutical and healthcare sectors”
 

Jim will be based at Cello Health’s BioConsulting Boston office.  

Ends

Cello Health
  Cello Health consists of three distinct capabilities:
  • Cello Health Insight: global marketing research and customer insight
  • Cello Health Consulting: strategic consultancy
  • Cello Health Communications: evidence and engagement
For further media information, please contact: Helen Lawn on +44 (0)1892 525141 or +44 (0)7879 818247, helen@helenlawn.co.uk; or Andy Newman on +44 (0)1603 465636 or +44 (0)7739 847964, andy@newmanassociates.co.uk   NR54023/CH/310715            

31st July 2015

Share

Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

Address:
11-13 Charterhouse Buildings
London
EC1M 7AP
UK

Latest content on this profile

Cello Health Launches New Social Insight & Analytics Business
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health
Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health
Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments
Rick Lang and Craig Lipski join the organization in senior digital roles
Cello Health
Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice
Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.
Cello Health
Maria Eletskaya joins Cello Health Insight
Bolstering senior team for expanding 'IQ' Quantitative practice
Cello Health